MUC1 and pancreatic neoplasm: MUC1, which mediates gemcitabine resistance in pancreatic cancer,26, 27 was repressed upon addition of genistein in both cell lines (Figure S2H) and this was corroborated using qPCR (Figure 3E) and western blot (Figure 3F).